Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC

by Marwa Alhothali, Mevin Mathew, Geeta Iyer, Harshani R. Lawrence, Shengyu Yang, Srikumar Chellappan, Jaya Padmanabhan
Published 2019-05-01

Lysophosphatidic acid acyltransferase beta regulates mTOR signaling.

by Michelle A Blaskovich, Vimala Yendluri, Harshani R Lawrence, Nicholas J Lawrence, Saïd M Sebti, Gregory M Springett
Published 2013-01-01

GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors

by Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, Daniel Delitto, José Trevino, Rays H. Y. Jiang, Muhammad Ayaz, Harshani R. Lawrence, Perry Kennedy, Saïd M. Sebti
Published 2018-12-01

Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer

by Jeremy J. McGuire, Jeremy S. Frieling, Chen Hao Lo, Tao Li, Ayaz Muhammad, Harshani R. Lawrence, Nicholas J. Lawrence, Leah M. Cook, Conor C. Lynch
Published 2021-02-01

Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition

by Manali Phadke, Lily L. Remsing Rix, Inna Smalley, Annamarie T. Bryant, Yunting Luo, Harshani R. Lawrence, Braydon J. Schaible, Yian A. Chen, Uwe Rix, Keiran S. M. Smalley
Published 2018-01-01